Sustainability in Pharma: CDMOs Move Fast to Cut Carbon Footprint
Sustainability is rapidly becoming a key performance indicator for CDMOs and a mechanism to lower the environmental impact of bringing new drugs to market. Read more in Contract Pharma’s latest article where Lyn McNeill provides an insight into how Almac is integrating innovations in green technologies within our clinical trial operations.
View Resource
